2008
DOI: 10.1016/j.jpeds.2008.01.023
|View full text |Cite
|
Sign up to set email alerts
|

Neonatal Vitamin B12 Deficiency Secondary to Maternal Subclinical Pernicious Anemia: Identification by Expanded Newborn Screening

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
17
0
7

Year Published

2008
2008
2017
2017

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(24 citation statements)
references
References 11 publications
0
17
0
7
Order By: Relevance
“…The expansion of newborn screening programmes to detect propionylcarnitine elevations has identified infants with deficiencies in the availability of vitamin B 12 (maternal B 12 deficiency, maternal subclinical pernicious anaemia and the cblC disorder) (Campbell et al 2005;Marble et al 2008). The detection of urinary MMA in the newborns as part of the newborn screening has also led to identification of maternal B 12 deficiency in a few centres (Michaud et al 1992).…”
Section: Discussionmentioning
confidence: 99%
“…The expansion of newborn screening programmes to detect propionylcarnitine elevations has identified infants with deficiencies in the availability of vitamin B 12 (maternal B 12 deficiency, maternal subclinical pernicious anaemia and the cblC disorder) (Campbell et al 2005;Marble et al 2008). The detection of urinary MMA in the newborns as part of the newborn screening has also led to identification of maternal B 12 deficiency in a few centres (Michaud et al 1992).…”
Section: Discussionmentioning
confidence: 99%
“…In our retrospective study of the benign form of MMAU (Sniderman et al 1999), MMA levels of 5-10 nmol/ml were observed in DBS of two patients who were identified in newborn screening by GC/MS using urine (Kuhara et al 1999), whereas urinary levels of methylcitric acid and DBS levels of C3 were not elevated. Detection of neonatal vitamin B 12 deficiency by MS/MS newborn screening has been reported in newborns whose mothers had vitamin B 12 deficiency based on elevated C3, although MMA levels in DBS were not mentioned (Wiley et al 1999, Campbell et al 2005, Marble et al 2008. In our study, it is not clear whether newborns with falsepositive results had vitamin B 12 deficiency or not, as their serum vitamin B 12 concentrations were not determined.…”
Section: Discussionmentioning
confidence: 58%
“…In our case, exclusive breastfeeding associated with low levels of maternal cobalamin has conditioned a deficit state of this vitamin. The normal newborn has enough vitamin B 12 for 6–8 months,3 8 even in the presence of a restricted diet or inadequate absorption, so the signs and symptoms of disease occur after a normal developmental period,1 2 4 6 characteristically between the 4th and 8th months of age,13 8 as in this case.…”
Section: Discussionmentioning
confidence: 72%
“…Vitamin B 12 deficiency should always be considered in children with neurologic symptoms associated with megaloblastosis and failure to thrive8 and must be included in the differential diagnosis of failure to thrive, regression of psychomotor development and neurologic, psychiatric and haematologic manifestations 3 10. The confirmation of diagnosis is made by elevated urinary or serum methylmalonic acid and serum homocysteine levels and decreased vitamin B 12 serum levels 2 5 7 13. Methylmalonic acid, except when caused by inborn errors of metabolism,1 6 13 18 is the most sensitive and specific markers of preclinical vitamin B 12 deficiency2 3 5 6 8 13 18 and is a useful tool for differentiating from folate deficiency 18.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation